A cure for type 1 diabetes has been dangled in front of our noses for decades like a carrot on a stick, with the promise that it’s only 5-10 years away. But research has recently accelerated, and the race to a cure is finally picking up speed. Find out how close we really are.
read more →
From stem cell and gene therapy advancements to expanded pump-sensor partnerships and new FDA medication approvals, this roundup hits the biggest diabetes breakthroughs in 2025.
read more →
Three big things need to happen for a cure for type 1 diabetes to be successful, and we’ve already crossed one of them off the list. Learn the latest research from three companies at the forefront of discovery, and find out when we think a functional cure will be realized (hint: It may be sooner than you think).
read more →
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
After seeing the struggles her patients faced living with type 1 diabetes, Dr. Tina Gupta was compelled to do more to help. She left clinical practice and joined Vertex Pharmaceuticals, a company researching treatment therapies that replace non-functioning beta cells with stem-cell- derived cells to try to reduce or eliminate the need for people with T1D to take insulin.
read more →
